Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy

Area of Science:

• Immunology
• Oncology
• Transplantation Medicine

Background:

• Malignancy is a significant complication after organ transplantation.
• The prevailing hypothesis attributes post-transplant neoplasm to immunosuppression-induced immune system impairment.
• This study investigates a potential autonomous cellular mechanism for metastasis associated with common immunosuppressants.

Purpose of the Study:

• To elucidate the cellular mechanisms by which cyclosporine and tacrolimus promote post-transplant malignancy.
• To evaluate the efficacy of rapamycin in reversing immunosuppressant-induced tumor invasiveness and metastasis.
• To explore transforming growth factor-beta (TGF-beta) as a therapeutic target in post-transplant cancer.

Main Methods:

• Experiments utilized severe combined immunodeficient (SCID) beige mice lacking T, B, and NK cells to assess drug effects independent of adaptive immunity.
• Tumor cell invasiveness and metastasis were evaluated in the presence of cyclosporine, tacrolimus, and rapamycin.
• The impact of anti-TGF-beta antibodies and rapamycin on tumor progression and TGF-beta levels was measured.

Main Results:

• Cyclosporine directly enhanced tumor cell invasiveness and promoted metastasis in SCID beige mice, effects partially reversed by anti-TGF-beta antibodies.
• Tacrolimus induced TGF-beta secretion by tumor cells, leading to increased metastasis in SCID beige mice.
• Rapamycin reversed the invasive phenotype, reduced TGF-beta levels, and inhibited tumor growth and metastasis in both immunocompetent and SCID beige mice.

Conclusions:

• Cyclosporine and tacrolimus promote post-transplant tumor metastasis through cell-autonomous mechanisms involving TGF-beta.
• Rapamycin demonstrates anti-tumorigenic properties by reversing invasiveness and reducing TGF-beta.
• Targeting TGF-beta represents a promising anti-tumor strategy in the context of organ transplantation and immunosuppression.